People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

40.06USD
19 Dec 2014
Price Change (% chg)

$-0.29 (-0.72%)
Prev Close
$40.35
Open
$40.24
Day's High
$40.58
Day's Low
$38.23
Volume
1,532,488
Avg. Vol
757,904
52-wk High
$40.58
52-wk Low
$27.51

Search Stocks

Sabella, Lauren 

Brief Biography

Ms. Lauren M. Sabella is Executive Vice President - Commercial Development of Acorda Therapeutics, Inc., since January 25, 2010. Ms. Sabella was the Founder and Principal of Tugboat Consulting Group, an independent consulting practice assisting companies in the commercialization process. Ms. Sabella also served as Corporate Officer and VP of Commercial Development at Altus Pharmaceuticals from May 2006 to September 2008, with responsibility for all aspects of commercialization. Prior to joining Altus, Ms. Sabella was employed by Boehringer Ingelheim Pharmaceuticals for 18 years in positions of increasing responsibility. In her last role, she served as VP of Sales, Eastern Zone, where she led the successful sales launch of Spiriva and ran both Primary Care and Specialty Divisions, including Neurology, Urology and Cardio/Pulmonary. Prior to this role, she had over ten years of marketing experience where she led several brand launches including Mobic, an NSAID which became a $1 billion brand. Ms. Sabella holds a B.B.A. from Hofstra University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
446,885 -- 385,724 1,060,110

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen

3,918,020

Michael Rogers

4,352,770

Lauren Sabella

1,060,110

Andrew Blight

1,484,560

Jane Wasman

2,159,620

Enrique Carrazana

1,618,840
As Of 30 Dec 2013
Search Stocks